In the present study, we found that THADA was remarkably expressed in tumor tissues of chemotherapy-sensitive GC patients by NGS of clinical GC samples and bioinformatics analysis of GEO data, whereas decreased THADA expression in tumor tissues was found to be an independent poor prognostic factor in GC patients receiving postoperative 5-FU adjuvant chemotherapy. This evidence concerns the gene THADA and neoplasm.